Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOS

Author:

Krum Henry1,Massie Barry2,Abraham William T.3,Dickstein Kenneth45,Kober Lars6,McMurray John J.V.7,Desai Ashkay8,Gimpelewicz Claudio9,Kandra Albert9,Reimund Bernard9,Rattunde Henning9,Armbrecht Juergen9,

Affiliation:

1. Centre of Cardiovascular Research & Education in Therapeutics, Department of Epidemiology & Preventive Medicine; Monash University/Alfred Hospital; Melbourne VIC 3004 Australia

2. University of California, San Francisco; San Francisco CA USA

3. Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute; The Ohio State University; Columbus OH USA

4. Stavanger University Hospital; Stavanger Norway

5. Institute of Internal Medicine; University of Bergen; Bergen Norway

6. Rigshospitalet Copenhagen University Hospital; Copenhagen Denmark

7. University of Glasgow; Glasgow UK

8. Harvard Medical School; Boston MA USA

9. Novartis Pharma AG; Basel Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3